Dr. John Hamer brings an unusual career path from tenured microbiology professor at Purdue to CEO of a public genomics company to venture investor, combined with over a decade of partnership with co-managing partner Dr. Kiersten Stead spanning both Monsanto Growth Ventures and DCVC Bio. He has been an early advocate for computational biology and AI in agriculture and drug discovery since before it became mainstream, and serves on boards of technically sophisticated platform biotechs like AbCellera and Umoja Biopharma where founders specifically seek his expertise in building next-generation technologies. Dr. John Hamer brings an unusual career path from tenured microbiology professor at Purdue to CEO of a public genomics company to venture investor, combined with over a decade of partnership with co-managing partner Dr. Kiersten Stead spanning both Monsanto Growth Ventures and DCVC Bio. He has been an early advocate for computational biology and AI in agriculture and drug discovery since before it became mainstream, and serves on boards of technically sophisticated platform biotechs like AbCellera and Umoja Biopharma where founders specifically seek his expertise in building next-generation technologies.